Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31–46.
Google Scholar
Hopkins JL, Lan L, Zou L. DNA repair defects in cancer and therapeutic opportunities. Genes Dev. 2022;36:278–93.
Google Scholar
Lu H, Yang M, Zhou Q. Reprogramming transcription after DNA damage: recognition, response, repair, and restart. Trends Cell Biol. 2023;33:682–94.
Google Scholar
Schwertman P, Bekker-Jensen S, Mailand N. Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers. Nat Rev Mol Cell Biol. 2016;17:379–94.
Google Scholar
Lee JH, Paull TT. Cellular functions of the protein kinase ATM and their relevance to human disease. Nat Rev Mol Cell Biol. 2021;22:796–814.
Google Scholar
Blackford AN, Jackson SP. ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response. Mol Cell. 2017;66:801–17.
Google Scholar
Shiloh Y, Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol. 2013;14:197–210.
Google Scholar
Lavin MF, Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu Rev Immunol. 1997;15:177–202.
Google Scholar
Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 1996;86:159–71.
Google Scholar
Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 1996;10:2411–22.
Google Scholar
Lee JH, Paull TT. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science. 2005;308:551–4.
Google Scholar
Carson CT, Schwartz RA, Stracker TH, Lilley CE, Lee DV, Weitzman MD. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J. 2003;22:6610–20.
Google Scholar
Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 2003;421:499–506.
Google Scholar
Sun Y, Jiang X, Xu Y, Ayrapetov MK, Moreau LA, Whetstine JR, et al. Histone H3 methylation links DNA damage detection to activation of the tumour suppressor Tip60. Nat Cell Biol. 2009;11:1376–82.
Google Scholar
Sun Y, Jiang X, Chen S, Fernandes N, Price BD. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc Natl Acad Sci USA 2005;102:13182–7.
Google Scholar
Li Z, Chen Y, Tang M, Li Y, Zhu W-G. Regulation of DNA damage-induced ATM activation by histone modifications. Genome Instability & Disease. 2020;1:20–33.
Google Scholar
Wu J, Zhang X, Zhang L, Wu CY, Rezaeian AH, Chan CH, et al. Skp2 E3 ligase integrates ATM activation and homologous recombination repair by ubiquitinating NBS1. Mol Cell. 2012;46:351–61.
Google Scholar
Chen H, Li Y, Li H, Chen X, Fu H, Mao D, et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature. 2024;631:663–9.
Google Scholar
Wang Z, Gong Y, Peng B, Shi R, Fan D, Zhao H, et al. MRE11 UFMylation promotes ATM activation. Nucleic Acids Res. 2019;47:4124–35.
Google Scholar
Chen C, Zhang L, Huang NJ, Huang B, Kornbluth S. Suppression of DNA-damage checkpoint signaling by Rsk-mediated phosphorylation of Mre11. Proc Natl Acad Sci USA 2013;110:20605–10.
Google Scholar
Kaidi A, Jackson SP. KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling. Nature. 2013;498:70–4.
Google Scholar
Bhoumik A, Singha N, O’Connell MJ, Ronai ZA. Regulation of TIP60 by ATF2 modulates ATM activation. J Biol Chem. 2008;283:17605–14.
Google Scholar
Liu S, Lv Q, Mao X, Dong H, Xu W, Du X, et al. O-GlcNAcylated RALY Contributes to Hepatocellular Carcinoma Cells Proliferation by Regulating USP22 mRNA Nuclear Export. Int J Biol Sci. 2024;20:3675–90.
Google Scholar
Qiao Y, Shi Q, Yuan X, Ding J, Li X, Shen M, et al. RNA binding protein RALY activates the cholesterol synthesis pathway through an MTA1 splicing switch in hepatocellular carcinoma. Cancer Lett. 2022;538:215711.
Google Scholar
Sun L, Wan A, Zhou Z, Chen D, Liang H, Liu C, et al. RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer. Gut. 2021;70:1698–712.
Google Scholar
Cornella N, Tebaldi T, Gasperini L, Singh J, Padgett RA, Rossi A, et al. The hnRNP RALY regulates transcription and cell proliferation by modulating the expression of specific factors including the proliferation marker E2F1. J Biol Chem. 2017;292:19674–92.
Google Scholar
Qin W, Kong N, Zhang Y, Dong S, Zhai H, Zhai X, et al. Nuclear ribonucleoprotein RALY targets virus nucleocapsid protein and induces autophagy to restrict porcine epidemic diarrhea virus replication. J Biol Chem. 2022;298:102190.
Google Scholar
Zhang Z, Feng AC, Salisbury D, Liu X, Wu X, Kim J, et al. Collaborative interactions of heterogenous ribonucleoproteins contribute to transcriptional regulation of sterol metabolism in mice. Nat Commun. 2020;11:984.
Google Scholar
Sallam T, Jones MC, Gilliland T, Zhang L, Wu X, Eskin A, et al. Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis. Nature. 2016;534:124–8.
Google Scholar
Hu H, Zhao K, Fang D, Wang Z, Yu N, Yao B, et al. The RNA binding protein RALY suppresses p53 activity and promotes lung tumorigenesis. Cell Rep. 2023;42:112288.
Google Scholar
Loughery J, Cox M, Smith LM, Meek DW. Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters. Nucleic Acids Res. 2014;42:7666–80.
Google Scholar
Zhao H, Gao S, Han Y, Xie D, Xuan L, Huang X, et al. Conversion of Ku80 K568 crotonylation to SUMOylation facilitates DNA non-homologous end joining and cancer radioresistance. Signal Transduct Target Ther. 2025;10:127.
Google Scholar
Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461:1071–8.
Google Scholar
Xie H, Liao L, Li J, Cai R, He H, Lu M. USP11 stabilizes RALY to promote FXYD5-mediated aerobic glycolysis and aggravate pancreatic cancer progression. Exp Cell Res. 2025;452:114758.
Google Scholar
Wu X, Niculite CM, Preda MB, Rossi A, Tebaldi T, Butoi E, et al. Regulation of cellular sterol homeostasis by the oxygen responsive noncoding RNA lincNORS. Nat Commun. 2020;11:4755.
Google Scholar
Savoca V, Rivosecchi J, Gaiatto A, Rossi A, Mosca R, Gialdini I, et al. TERRA stability is regulated by RALY and polyadenylation in a telomere-specific manner. Cell Rep. 2023;42:112406.
Google Scholar
Rossi A, Moro A, Tebaldi T, Cornella N, Gasperini L, Lunelli L, et al. Identification and dynamic changes of RNAs isolated from RALY-containing ribonucleoprotein complexes. Nucleic Acids Res. 2017;45:6775–92.
Google Scholar
Pan Z, Du S, Wang K, Guo X, Mao Q, Feng X, et al. Downregulation of a Dorsal Root Ganglion-Specifically Enriched Long Noncoding RNA is Required for Neuropathic Pain by Negatively Regulating RALY-Triggered Ehmt2 Expression. Adv Sci (Weinh). 2021;8:e2004515.
Google Scholar
Kulkarni S, Lied A, Kulkarni V, Rucevic M, Martin MP, Walker-Sperling V, et al. CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome. Nat Immunol. 2019;20:824–34.
Google Scholar
Legube G, Linares LK, Lemercier C, Scheffner M, Khochbin S, Trouche D. Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation. EMBO J. 2002;21:1704–12.
Google Scholar
Morgan MA, Lawrence TS. Molecular pathways: overcoming radiation resistance by targeting DNA damage response pathways. Clin Cancer Res. 2015;21:2898–904.
Google Scholar
Yang L, Wei W, Yuan X, Guo E, Peng P, Wang J, et al. Targeting DNA damage repair to enhance antitumor immunity in radiotherapy: mechanisms and opportunities. Int J Mol Sci. 2025;26:3743.
Lavin MF. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol. 2008;9:759–69.
Google Scholar
Kastan MB, Lim DS. The many substrates and functions of ATM. Nat Rev Mol Cell Biol. 2000;1:179–86.
Google Scholar
Lisby M, Barlow JH, Burgess RC, Rothstein R. Choreography of the DNA damage response: spatiotemporal relationships among checkpoint and repair proteins. Cell. 2004;118:699–713.
Google Scholar
Cassani C, Vertemara J, Bassani M, Marsella A, Tisi R, Zampella G, et al. The ATP-bound conformation of the Mre11-Rad50 complex is essential for Tel1/ATM activation. Nucleic Acids Res. 2019;47:3550–67.
Google Scholar
Marechal A, Zou L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol. 2013;5:a012716.
Sun Y, Xu Y, Roy K, Price BD. DNA damage-induced acetylation of lysine 3016 of ATM activates ATM kinase activity. Mol Cell Biol. 2007;27:8502–9.
Google Scholar
Peng L, Ling H, Yuan Z, Fang B, Bloom G, Fukasawa K, et al. SIRT1 negatively regulates the activities, functions, and protein levels of hMOF and TIP60. Mol Cell Biol. 2012;32:2823–36.
Google Scholar
Wang J, Chen J. SIRT1 regulates autoacetylation and histone acetyltransferase activity of TIP60. J Biol Chem. 2010;285:11458–64.
Google Scholar
Cheng Z, Ke Y, Ding X, Wang F, Wang H, Wang W, et al. Functional characterization of TIP60 sumoylation in UV-irradiated DNA damage response. Oncogene. 2008;27:931–41.
Google Scholar
Yi J, Huang X, Yang Y, Zhu WG, Gu W, Luo J. Regulation of histone acetyltransferase TIP60 function by histone deacetylase 3. J Biol Chem. 2014;289:33878–86.
Google Scholar
Zheng H, Seit-Nebi A, Han X, Aslanian A, Tat J, Liao R, et al. A posttranslational modification cascade involving p38, Tip60, and PRAK mediates oncogene-induced senescence. Mol Cell. 2013;50:699–710.
Google Scholar
Lemercier C, Legube G, Caron C, Louwagie M, Garin J, Trouche D, et al. Tip60 acetyltransferase activity is controlled by phosphorylation. J Biol Chem. 2003;278:4713–8.
Google Scholar
Brooks CL, Gu W. p53 ubiquitination: Mdm2 and beyond. Mol Cell. 2006;21:307–15.
Google Scholar
He H, Zhou Q, Zhang Y, Li Y, Ding L, Shen T, et al. PTBP1 regulates DNMT3B alternative splicing by interacting with RALY to enhance the radioresistance of prostate cancer. Adv Sci (Weinh). 2024;11:e2405997.
Google Scholar
